Literature DB >> 6402930

Improved exercise tolerance of the polycythemic lung patient following phlebotomy.

K G Chetty, S E Brown, R W Light.   

Abstract

The present study evaluated the effects of therapeutic phlebotomy on the exercise tolerance and the maximal carbon dioxide output of polycythemic patients with chronic obstructive pulmonary disease. Fifteen maximal exercise studies were performed before and after phlebotomy in patients with moderate to severe chronic obstructive pulmonary disease (mean forced expiratory volume in one second [FEV1]= 970 ml). After phlebotomy there were no significant differences in pulmonary function, blood gases, oxygen consumption, or carbon dioxide production at rest. However, after phlebotomy there was a significant increase in the exercise tolerance of the patients. The mean workload, the duration of exercise, the maximal oxygen consumption, the maximal carbon dioxide production, and the ventilation at maximal exercise all increased significantly. The improved exercise tolerance after phlebotomy appeared due to an increased cardiac output generated mainly through an increased stroke volume. We hypothesize that the increased stroke volume was due to a higher ejection fraction of the right ventricle secondary to a lower pulmonary artery pressure. This study provides further evidence that patients with chronic obstructive pulmonary disease who have polycythemia benefit by therapeutic interventions that maintain their hematocrits below 55 percent.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6402930     DOI: 10.1016/0002-9343(83)90960-9

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  4 in total

Review 1.  The outpatient diagnosis and management of chronic obstructive pulmonary disease: pharmacotherapy, administration of supplemental oxygen, and smoking cessation techniques.

Authors:  R M Schapira; L F Reinke
Journal:  J Gen Intern Med       Date:  1995-01       Impact factor: 5.128

2.  Optimal hematocrit for maximal exercise performance in acute and chronic erythropoietin-treated mice.

Authors:  Beat Schuler; Margarete Arras; Stephan Keller; Andreas Rettich; Carsten Lundby; Johannes Vogel; Max Gassmann
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-04       Impact factor: 11.205

3.  Calf blood flow and oxygen carriage after reversal of polycythaemia secondary to hypoxic lung disease.

Authors:  P J Wallis; M C Apps; A C Newland; D W Empey
Journal:  Thorax       Date:  1986-04       Impact factor: 9.139

4.  Haemoglobin as a biomarker for clinical outcomes in chronic obstructive pulmonary disease.

Authors:  Aparna Balasubramanian; Robert J Henderson; Nirupama Putcha; Ashraf Fawzy; Sarath Raju; Nadia N Hansel; Neil R MacIntyre; Robert L Jensen; Gregory L Kinney; William W Stringer; Craig P Hersh; Russell P Bowler; Richard Casaburi; MeiLan K Han; Janos Porszasz; Barry J Make; Meredith C McCormack; Robert A Wise
Journal:  ERJ Open Res       Date:  2021-07-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.